Drawing for TELPERIAN

USPTO serial 97486365

TELPERIAN

Reviewed by CopyMark Law Group

Reg. 7132301Status 700Registered
Filing date
Status date
Registration date
Aug 8, 2023
Examiner
JOHN,CRISTEL M
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with TELPERIAN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Megan R. Bradshaw

Megan R. Bradshaw Pirkey Barber PLLC1801 East 6th Street, Suite 300Austin, TX 78702United States

Goods and services

ClassDescriptionStatusFirst use
035Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business consulting and management in the field of clinical trials, namely, providing information management servicesACTIVE—
042Consulting services for others in the field of design, planning, and implementation project management of scientific research, clinical trials, clinical trial simulation, data review, and machine learning analysis; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Software as a service (SAAS) services featuring software for designing and implementing clinical trials in the pharmaceutical field, namely, clinical data analysis and regulatory reporting for pharmaceutical research, clinical trial simulation, data review, and machine learning analysisACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 7, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 7, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 7, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 7, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jan 7, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Nov 22, 2023ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Nov 8, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 8, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 8, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 8, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Nov 8, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Sep 22, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 22, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 22, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 22, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 22, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 8, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 8, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 1, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 1, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 1, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 1, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Aug 1, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 23, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 23, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 3, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 17, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 17, 2023DOCKASSIGNED TO EXAMINER—
Jul 21, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 5, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance